PRKAA1 and metabolic dysfunction-associated steatotic liver disease: Furthermore, Min HK et al. showed that the accumulation of triglycerides and free cholesterol in nonalcoholic fatty liver disease (NAFLD) was accompanied by the inhibition of AMPK activity and increased expression of SREBP-2 and HMGCR [11].